As a consequence, since the CFTR gene was discovered as the cause of CF, there has been considerable interest in developing gene therapy, as exemplified by viral and non-viral vectors, aerosolized and intratracheal administration, single-dose and multiple-dose, wild-type gene integration, and gene editing tools. The gene discussed is CFTR; the disease is cystic fibrosis.